Clusterin (CLU) is the third most important associated risk gene in cognitive disorders. Regarding the controversy about the association of CLU rs11136000 with mild cognitive impairment (MCI), the aim of this study was to investigate a putative association of CLU rs11136000 with MCI as well as the serum biological factors with a special attention to the age as a main dimension of a multifactorial elderly disease in an Iranian elderly cohort in which the mentioned association was not previously investigated. The study also checked the association between diabetes and MCI in this population. A population of 418 individuals containing 236 MCI and 192 control subjects was recruited from the Amirkola health and aging population cohort. Serum biological indexes were assessed by biochemical and enzyme-linked immunosorbent assay, and rs11136000 genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism. Bioinformatics analyses were used to identify the putative effect of rs11136000 on the secondary structure of RNA and chromatin location in different cell lines and tissues. Type 2 diabetes was present with a higher proportion in the MCI group in comparison with the control group (P = 0.041). The frequency of the C allele of CLU rs11136000 was significantly different between cases and controls and was associated with MCI risk (OR 1.79, P = 0.019). Under a dominant genetic model, the CC genotype showed a predisposing effect in individuals aged ≥ 75 years (OR 3.33, P = 0.0004). Interestingly, under an over-dominant model, the CT genotype had a protective effect in this population (OR 4.52, P = < 0.0001). We also found a significant association between the genotypes and high-density lipoprotein (HDL) levels in MCI patients (P = 0.0004). Bioinformatics analysis showed that rs11136000 is located in the transcribed region without any regulatory features such as being enhancer or insulator. Also, the T>C transition of CLU rs11136000 could not cause significant mRNA folding (P = 0.950). Contrary to other studies on Asian populations, this study demonstrated an association between rs11136000 and MCI in an elderly Iranian population. This study also suggests that an age-dependent approach to the previous studies may be performed in order to revise the previous belief in this geographical area. The rs11136000 genotypes in combination with HDL levels and knowledge about diabetes background may be used as a predictive medicine tool for cognitive disorders.
ClusterinRs11136000 Mild cognitive impairment HDL Age Predictive medicine
This is a preview of subscription content, log in to check access.
The authors would like to acknowledge all participants of this study. The present study was supported by a Grant No. 9339436 of Babol University of Medical Sciences, Babol, Iran.
Compliance with ethical standards
Conflict of interest
Authors declare no conflict of interest.
Mariani E, Monastero R, Mecocci P (2007) Mild cognitive impairment: a systematic review. J Alzheimers Dis 12(1):23–35PubMedCrossRefGoogle Scholar
Corneveaux JJ et al (2010) Association of CR1, CLU and PICALM with Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Mol Genet 19(16):3295–3301CrossRefGoogle Scholar
Lancaster TM et al (2015) Alzheimer’s disease risk variant in CLU is associated with neural inefficiency in healthy individuals. Alzheimer’s Dement 11(10):1144–1152CrossRefGoogle Scholar
Bertram L et al (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17PubMedCrossRefGoogle Scholar
Gu H et al (2011) Association of clusterin gene polymorphisms with late-onset Alzheimer’s disease. Dementia Geriatr Cognit Disord 32(3):198–201CrossRefGoogle Scholar
Han Z et al (2018) Analyzing 74,248 samples confirms the association between clu rs11136000 polymorphism and Alzheimer’s disease in caucasian but not Chinese population. Sci Rep 8(1):11062PubMedPubMedCentralCrossRefGoogle Scholar
Jen MY, Gossman WG (2018) Predictive medicine. StatPearls, OrlandoGoogle Scholar
Hosseini SR et al (2014) Cohort profile: the Amirkola health and ageing project (AHAP). Int J Epidemiol 43(5):1393–1400PubMedCrossRefGoogle Scholar
Ansari NN et al (2010) Validation of a mini-mental state examination (MMSE) for the Persian population: a pilot study. Appl Neuropsychol 17(3):190–195PubMedCrossRefGoogle Scholar
Cai R et al (2016) Plasma clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front Aging Neurosci 8:179PubMedPubMedCentralCrossRefGoogle Scholar
Tan L et al (2016) Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts. Sci Rep 6:26027PubMedPubMedCentralCrossRefGoogle Scholar